Literature DB >> 19437550

Activation of Toll-like receptors inhibits herpes simplex virus-1 infection of human neuronal cells.

Yu Zhou1, Li Ye, Qi Wan, Lin Zhou, Xu Wang, Jieliang Li, Shuxian Hu, Dunjin Zhou, Wenzhe Ho.   

Abstract

Toll-like receptors (TLRs) play an essential role in initiating intracellular type I interferon (IFN)-mediated innate immunity against viral infections. We examined whether human neuronal cells (primary human neurons, NT2-N and CHP-212 cells) express TLRs and mount type I IFN-mediated innate immunity against herpes simplex virus-1 (HSV-1) infection. Human neuronal cells expressed TLR family members 1-10 and IFN-alpha/beta. The activation of TLR3 or TLR8 by double-stranded RNA (poly-I:C) or single-stranded RNA (ssRNA) induced IFN-alpha/beta expression. In addition, HSV-1 infection of human neuronal cells induced IFN-alpha expression. Investigation of the mechanisms showed that poly-I:C or ssRNA treatment enhanced the expression of several IFN regulatory factors. Importantly, the activation of TLR3 or TLR8 by poly-I:C or ssRNA prior to HSV-1 infection reduced the susceptibility of the neuronal cells to infection. These observations indicate that human neuronal cells possess intracellular TLR-mediated innate immune protection against HSV-1 infection. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19437550      PMCID: PMC3935181          DOI: 10.1002/jnr.22110

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  52 in total

1.  Herpes simplex virus-mediated expression of the axonal protein tau in human model neurons (NT2-N cells).

Authors:  T Fath; J Eidenmüller; T Maas; R Brandt
Journal:  Microsc Res Tech       Date:  2000-01-15       Impact factor: 2.769

Review 2.  The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors.

Authors:  Tadatsugu Taniguchi; Akinori Takaoka
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 3.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 5.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

6.  Toll-like receptor 3 activation induces antiviral immune responses in mouse sertoli cells.

Authors:  Donatella Starace; Roberta Galli; Alessio Paone; Paola De Cesaris; Antonio Filippini; Elio Ziparo; Anna Riccioli
Journal:  Biol Reprod       Date:  2008-07-02       Impact factor: 4.285

7.  Upregulation of the TLR3 pathway by Kaposi's sarcoma-associated herpesvirus during primary infection.

Authors:  John West; Blossom Damania
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  Immature human NT2 cells grafted into mouse brain differentiate into neuronal and glial cell types.

Authors:  A Ferrari; E Ehler; R M Nitsch; J Götz
Journal:  FEBS Lett       Date:  2000-12-08       Impact factor: 4.124

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Expression and regulation of antiviral protein APOBEC3G in human neuronal cells.

Authors:  Yan-Jian Wang; Xu Wang; Hui Zhang; Lin Zhou; Shi Liu; Dennis L Kolson; Li Song; Li Ye; Wen-Zhe Ho
Journal:  J Neuroimmunol       Date:  2008-11-21       Impact factor: 3.478

View more
  33 in total

1.  HSV Recombinant Vectors for Gene Therapy.

Authors:  Roberto Manservigi; Rafaela Argnani; Peggy Marconi
Journal:  Open Virol J       Date:  2010-06-18

2.  IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons.

Authors:  Lin Zhou; Jieliang Li; Xu Wang; Li Ye; Wei Hou; Jie Ho; He Li; Wenzhe Ho
Journal:  J Neurovirol       Date:  2011-04-16       Impact factor: 2.643

3.  Human neuronal cells possess functional cytoplasmic and TLR-mediated innate immune pathways influenced by phosphatidylinositol-3 kinase signaling.

Authors:  Daniel C Peltier; Allison Simms; Jocelyn R Farmer; David J Miller
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

4.  Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.

Authors:  Jieliang Li; Li Ye; Xu Wang; Shuxian Hu; Wenzhe Ho
Journal:  J Neurosci Res       Date:  2011-11-04       Impact factor: 4.164

Review 5.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

Review 6.  Oncolytic HSV-1 virotherapy: clinical experience and opportunities for progress.

Authors:  Balveen Kaur; E Antonio Chiocca; Timothy P Cripe
Journal:  Curr Pharm Biotechnol       Date:  2012-07       Impact factor: 2.837

7.  Role of toll-like receptors in multiple sclerosis.

Authors:  Socorro Miranda-Hernandez; Alan G Baxter
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

8.  Toll-like receptor 3 signaling inhibits simian immunodeficiency virus replication in macrophages from rhesus macaques.

Authors:  Ming Sang; Jin-Biao Liu; Ming Dai; Jian-Guo Wu; Wen-Zhe Ho
Journal:  Antiviral Res       Date:  2014-10-23       Impact factor: 5.970

9.  TLR3 activation efficiency by high or low molecular mass poly I:C.

Authors:  Yu Zhou; Ming Guo; Xu Wang; Jielang Li; Yizhong Wang; Li Ye; Ming Dai; Li Zhou; Yuri Persidsky; Wenzhe Ho
Journal:  Innate Immun       Date:  2012-10-03       Impact factor: 2.680

Review 10.  Toll-Like Receptor Signaling in Depression.

Authors:  Leandra K Figueroa-Hall; Martin P Paulus; Jonathan Savitz
Journal:  Psychoneuroendocrinology       Date:  2020-09-01       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.